Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/3597Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Basheer, Shamnad | - |
| dc.date.accessioned | 2009-03-31T05:21:59Z | - |
| dc.date.available | 2009-03-31T05:21:59Z | - |
| dc.date.issued | 2006-09 | - |
| dc.identifier.issn | 0971-7544 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/3597 | - |
| dc.description | 334-358 | en_US |
| dc.description.abstract | If the patented gene is not absolutely essential for use by a downstream researcher, in that there are substitutes available to work with or ways in which the patent in question could be circumvented, clearly the patented gene will not block the downstream researcher. In this sense, while the first part of the title, “Block Me Not,” expresses the blocking concern in general (the thousand-mile journey), the latter part, “How ‘Essential’ Are Patented Genes?” is the more specific question that this article seeks to address (the first step in this long and arduous journey) | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.source | JIPR Vol.11(5) [September 2006] | en_US |
| dc.subject | Gene patents | en_US |
| dc.subject | restricted access | en_US |
| dc.subject | biopharmaceutical | en_US |
| dc.title | Block Me Not: How “Essential” are Patented Genes | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | JIPR Vol.11(5) [September 2006] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| JIPR 11(5) 334-358.pdf | 261.65 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.